Filing Details

Accession Number:
0001209191-11-010612
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-17 16:34:07
Reporting Period:
2011-02-16
Filing Date:
2011-02-17
Accepted Time:
2011-02-17 16:34:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1430788 D. Bryce Carmine Lilly Corporate Center
Indianapolis IN 46285
Evp And Pres, Lilly Bio-Meds No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-02-16 3,100 $34.49 103,407 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,218 Indirect 401(k)
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010.